Chiesi USA, Inc. Recalls 2026: Drugs & Supplements

Chiesi USA, Inc. recalls

RecallSweep is tracking 2 recall notices naming Chiesi USA, Inc. in the last 180 days, issued by FDA. The most recent is dated July 22, 2026 and the oldest in this window April 1, 2026. They cover Drugs & Supplements.

This page lists what the issuing agencies published. It is not a statement about Chiesi USA, Inc. beyond those notices — open each official notice for the authoritative detail.

Recall notices naming Chiesi USA, Inc.

2 recalls.

July 22, 2026 FDA Class II Drugs & Supplements

Chiesi USA, Inc.: CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary,…

Affected quantity: 44280 vials

Hazard
Lack of Assurance of Sterility

Details
Distribution: Nationwide within the United States. Recall #D-0689-2026, initiated 20260706. Voluntary: Firm initiated.

Products affected
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.

Recall status
Ongoing

Look up recall #D-0689-2026 in the FDA enforcement database ↗

April 1, 2026 FDA Class II Drugs & Supplements

Chiesi USA, Inc.: CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

Affected quantity: 7,235 vials

Hazard
Lack of Assurance of Sterility

Details
Distribution: Nationwide within the United States. Recall #D-0402-2026, initiated 20260317. Voluntary: Firm initiated.

Products affected
CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

Recall status
Ongoing

Look up recall #D-0402-2026 in the FDA enforcement database ↗

Chiesi USA, Inc. recalls

Recall notices naming Chiesi USA, Inc.

Chiesi USA, Inc.: CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary,…

Chiesi USA, Inc.: CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.

Categories

Agencies

Other brands recalled in the same categories

Browse